Presentations symposium 4 April 2008, Utrecht

• Bock, G.G. de: Benefits and risks of breast cancer screening among women with a familial or genetic predisposition: validation of a simulation model using published data
• Botma, A.: BMI and colorectal adenomas in familial colorectal cancer
• Douma, K.F.L.: Patient-related outcomes of Familial Adenomatous Polyposis (FAP): compliance, distress and life course
• Hoogerbrugge, N.: The impact of a false positive MRI on the choice for mastectomy in BRCA mutation carriers is limited
• Hullu, J. de: Annual gynecological surveillance in Lynch Syndrome
• Jansen-van der Weide, M.C.: An example of gene-environment interaction: mammography screening and radiation-induced breast cancer among women with a familial or genetic predisposition
• Joerink, M.C.: Genotype-phenotype correlations in MUTYH associated polyposis (MAP)
• Kets, M. Compound heterozygosity for two MSH2 mutations suggests mild consequences of the initiation codon mutation c.1A>G of MSH2
• Kleibeuker, J.H.: Screening for small bowel cancer in Lynch Syndrome by capsule endoscopy: announcement of a Dutch multi-centre study
• Klift, H. van der : Gene conversion rates between PMS2 and its pseudogene PMS2CL: impact on the reliability of current mutation scanning.
• Kluijt, I.: Endoscopic ultrasonography is a valuable tool with high yield in screening of patients at hig-risk for pancreatic cancer
• Kriege, M: Sensitivity to first-line chemotherapy for metastatic breast cancer in BRCA1 and BRCA2 mutation carriers
• Landsbergen, K.M.: The impact of a BRCA support-information group on the choice for a preventive mastectomy is limited
• Lier, M.G.F. van: Underutilization of MSI-analysis in patients with colorectal cancer at high risk for Lynch Syndrome
• Ligtenberg, M.: Multidisciplinary national guidelines on hereditary colorectal cancer: a central role for molecular testing for the early recognition of Lynch Syndrome
• Luijt, R.B. van der: Multi-disciplinary assessment of unclassified variants in the BRCA1 and BRCA2 genes identified by clinical genetic testing
• Meulen-de Jong, A.E. van der: Prevalence of adenomas in familial colorectal cancer (the FACTS study)
• Middeldorp, J.: High frequency of copy neutral LOH in MUTYH associated polyposis carcinomas
• Miranda, N.F.C.C. de: MUTYH-associated polyposis carcinomas frequently alter HLA class I expression as an immune-evasive mechanism
• Overbeek, L.: A tailored implementation strategy is effective to involve pathologists in the recognition of patients at risk for Lynch Syndrome
• Pijpe A.: Physical activity and the risk of breast cancer in BRCA1/2 mutation carriers in the Netherlands
• Ramsoekh, D.: Mutation prediction models in Lynch Syndrome: external validation in a clinical genetics setting
• Rhee, J. van der: Effectiveness of screening for melanoma in families with a foundermutation in CDKN2A
• Vos, W.H. de: Results of surveillance for hereditary pancreatic cancer using annual MRI (CP)
• Vreeswijk, M.P.G.: The use of splice site prediction programs as a reliable tool to select intronic variants in BRCA1 and BRCA2 that affect RNA splicing